PD解决方案:新的和旧的

Jose A. Diaz-Buxo MD, Dixie-Ann Sawin PhD, Rainer Himmele MD
{"title":"PD解决方案:新的和旧的","authors":"Jose A. Diaz-Buxo MD,&nbsp;Dixie-Ann Sawin PhD,&nbsp;Rainer Himmele MD","doi":"10.1002/dat.20601","DOIUrl":null,"url":null,"abstract":"<p>Peritoneal dialysis (PD) solutions have evolved since Boen described the appropriate composition of a suitable fluid comprising an osmotic agent, electrolytes, and buffer substance in 1969. New solutions introducing alternative osmotic agents and bicarbonate as an alternative to lactate-buffered solutions have been developed. These so-called biocompatible solutions belong to a very heterogeneous group of PD fluids that share some features but are distinct in other aspects. All biocompatible solutions have a substantially reduced level of toxic glucose degradation products (GDPs). However, the new solutions differ in their absolute GDP content, osmotic agent, buffer substance, and pH. The differences from the conventional solutions and the characteristics of the distinct new solutions are presented in this review together with a discussion of their potential clinical benefits and implications. Dial. Transplant. © 2011 Wiley Periodicals, Inc.</p>","PeriodicalId":51012,"journal":{"name":"Dialysis & Transplantation","volume":"40 8","pages":"356-363"},"PeriodicalIF":0.0000,"publicationDate":"2011-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/dat.20601","citationCount":"3","resultStr":"{\"title\":\"PD solutions: New and old\",\"authors\":\"Jose A. Diaz-Buxo MD,&nbsp;Dixie-Ann Sawin PhD,&nbsp;Rainer Himmele MD\",\"doi\":\"10.1002/dat.20601\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Peritoneal dialysis (PD) solutions have evolved since Boen described the appropriate composition of a suitable fluid comprising an osmotic agent, electrolytes, and buffer substance in 1969. New solutions introducing alternative osmotic agents and bicarbonate as an alternative to lactate-buffered solutions have been developed. These so-called biocompatible solutions belong to a very heterogeneous group of PD fluids that share some features but are distinct in other aspects. All biocompatible solutions have a substantially reduced level of toxic glucose degradation products (GDPs). However, the new solutions differ in their absolute GDP content, osmotic agent, buffer substance, and pH. The differences from the conventional solutions and the characteristics of the distinct new solutions are presented in this review together with a discussion of their potential clinical benefits and implications. Dial. Transplant. © 2011 Wiley Periodicals, Inc.</p>\",\"PeriodicalId\":51012,\"journal\":{\"name\":\"Dialysis & Transplantation\",\"volume\":\"40 8\",\"pages\":\"356-363\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/dat.20601\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dialysis & Transplantation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/dat.20601\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dialysis & Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dat.20601","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

自1969年Boen描述了由渗透剂、电解质和缓冲物质组成的合适液体的适当组成以来,腹膜透析(PD)溶液不断发展。新的解决方案引入替代渗透剂和碳酸氢盐作为替代乳酸缓冲溶液已经开发。这些所谓的生物相容性溶液属于一组非常异质的PD液,它们有一些共同的特征,但在其他方面却截然不同。所有生物相容性溶液的毒性葡萄糖降解产物(gdp)水平都大大降低。然而,新溶液在绝对GDP含量、渗透剂、缓冲物质和ph值方面存在差异。本文将介绍与传统溶液的差异以及不同新溶液的特点,并讨论其潜在的临床益处和意义。拨号。移植。©2011 Wiley期刊公司
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PD solutions: New and old

Peritoneal dialysis (PD) solutions have evolved since Boen described the appropriate composition of a suitable fluid comprising an osmotic agent, electrolytes, and buffer substance in 1969. New solutions introducing alternative osmotic agents and bicarbonate as an alternative to lactate-buffered solutions have been developed. These so-called biocompatible solutions belong to a very heterogeneous group of PD fluids that share some features but are distinct in other aspects. All biocompatible solutions have a substantially reduced level of toxic glucose degradation products (GDPs). However, the new solutions differ in their absolute GDP content, osmotic agent, buffer substance, and pH. The differences from the conventional solutions and the characteristics of the distinct new solutions are presented in this review together with a discussion of their potential clinical benefits and implications. Dial. Transplant. © 2011 Wiley Periodicals, Inc.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Dialysis & Transplantation
Dialysis & Transplantation 医学-工程:生物医学
自引率
0.00%
发文量
1
期刊最新文献
Extensive vascular calcification in diabetic uremic patient A product of medical advancements Dialysis care: Three decades later Persistent hypophosphathemia recovered with cinacalcet in a late renal transplanted patient How the latest evidence from clinical research informs patient care
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1